About Asimov
Asimov builds in the startup category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.
What they do: Asimov builds tools to program living cells. Biotech
Funding context: Andreessen Horowitz, $175M Series B in 2023
Recent milestones:
- Asimov appears in the 100Xfounder startup directory import feed.
Why it Matters
Asimov matters because asimov builds tools to program living cells. Biotech
Funding Snapshot
- Series B | Andreessen Horowitz, $175M Series B in 2023
Hiring Roles
This company is actively hiring.
Meet the Founders
Asimov Team
Founder & CEO
